Kelly E Sullivan, Rebecca C T Reader, Vicky K Yang
{"title":"Evaluation of Maropitant-Induced Changes in the Electrocardiogram of Healthy Dogs and Comparison of Three Methods for QT Interval Correction.","authors":"Kelly E Sullivan, Rebecca C T Reader, Vicky K Yang","doi":"10.1111/vec.13476","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To assess for ECG changes, particularly affecting the QT interval, in healthy dogs administered maropitant and to compare methods of QT interval correction in dogs.</p><p><strong>Design: </strong>Prospective interventional pre-post study.</p><p><strong>Setting: </strong>University teaching hospital.</p><p><strong>Animals: </strong>Twenty-seven healthy, privately owned dogs.</p><p><strong>Interventions: </strong>After physical examination, bloodwork, and baseline six-lead ECG, dogs were administered a standard antiemetic dose of maropitant (1 mg/kg, SC). A follow-up ECG was performed 35-65 min later, after maximum plasma concentration was expected to be reached.</p><p><strong>Measurements and main results: </strong>Twenty dogs completed the study. No adverse effects of maropitant were witnessed apart from apparent pain on injection, and no tachyarrhythmias or bradyarrhythmias were observed. ECG measurements included RR interval, QT interval, TQ interval, PR interval, P wave duration and amplitude, and QRS complex duration and amplitude. Instantaneous heart rate (HR) was determined based on the RR interval, followed by HR correction of QRS complex duration and QT interval using the Rautaharju, Van de Water, and Hodges formulas. Cardiac restitution was also evaluated using the QT/TQ ratio. Comparisons made before and after maropitant administration showed subtle prolongation of the QTc that only reached significance with the Van de Water formula and no change in the QT/TQ ratio. A significant reduction in P wave amplitude was observed with maropitant. An increase in variability between formulas at higher HRs was seen when QT interval correction formulas across a range of HRs were compared.</p><p><strong>Conclusions: </strong>Maropitant administered subcutaneously at a standard antiemetic dose may induce a slight prolongation of the QTc and a reduction in P wave amplitude that are unlikely to promote tachyarrhythmias such as torsades de pointes or become clinically relevant in healthy dogs. The Van de Water formula may be more accurate across a wide range of HRs in dogs than the Rautaharju and Hodges formulas.</p>","PeriodicalId":74015,"journal":{"name":"Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)","volume":" ","pages":"e13476"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/vec.13476","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To assess for ECG changes, particularly affecting the QT interval, in healthy dogs administered maropitant and to compare methods of QT interval correction in dogs.
Interventions: After physical examination, bloodwork, and baseline six-lead ECG, dogs were administered a standard antiemetic dose of maropitant (1 mg/kg, SC). A follow-up ECG was performed 35-65 min later, after maximum plasma concentration was expected to be reached.
Measurements and main results: Twenty dogs completed the study. No adverse effects of maropitant were witnessed apart from apparent pain on injection, and no tachyarrhythmias or bradyarrhythmias were observed. ECG measurements included RR interval, QT interval, TQ interval, PR interval, P wave duration and amplitude, and QRS complex duration and amplitude. Instantaneous heart rate (HR) was determined based on the RR interval, followed by HR correction of QRS complex duration and QT interval using the Rautaharju, Van de Water, and Hodges formulas. Cardiac restitution was also evaluated using the QT/TQ ratio. Comparisons made before and after maropitant administration showed subtle prolongation of the QTc that only reached significance with the Van de Water formula and no change in the QT/TQ ratio. A significant reduction in P wave amplitude was observed with maropitant. An increase in variability between formulas at higher HRs was seen when QT interval correction formulas across a range of HRs were compared.
Conclusions: Maropitant administered subcutaneously at a standard antiemetic dose may induce a slight prolongation of the QTc and a reduction in P wave amplitude that are unlikely to promote tachyarrhythmias such as torsades de pointes or become clinically relevant in healthy dogs. The Van de Water formula may be more accurate across a wide range of HRs in dogs than the Rautaharju and Hodges formulas.
目的:评价使用马洛匹坦的健康犬的心电图变化,特别是对QT间期的影响,并比较QT间期矫正方法。设计:前瞻性介入前后研究。单位:大学教学医院。动物:27只健康的私人养狗。干预措施:在身体检查、血液检查和基线六导联心电图后,给狗服用标准止吐剂量的马洛匹坦(1mg /kg, SC)。在预计达到最大血药浓度后,随访心电图35-65分钟。测量和主要结果:20只狗完成了研究。除注射时明显疼痛外,未观察到马洛匹坦的不良反应,未观察到快速性心律失常或慢速性心律失常。心电图测量包括RR间期、QT间期、TQ间期、PR间期、P波持续时间和幅值、QRS复合持续时间和幅值。根据RR间期测定瞬时心率(HR),然后使用Rautaharju、Van de Water和Hodges公式对QRS复合持续时间和QT间期进行HR校正。心脏恢复也用QT/TQ比值进行评估。马洛匹坦给药前后的比较显示,QTc有轻微延长,只有Van de Water公式才有意义,QT/TQ比没有变化。马洛匹坦可显著降低P波振幅。当比较不同hr范围内的QT间期校正公式时,可以看到较高hr时公式之间的变异性增加。结论:标准止吐剂量的马洛匹坦皮下给药可能会导致QTc的轻微延长和P波振幅的降低,这些不太可能促进速性心律失常,如点扭转或在健康犬中具有临床相关性。Van de Water公式可能比Rautaharju和Hodges公式在狗的大范围hr中更准确。